Related Experiment Video
Updated: Nov 16, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
An In Silico Method for Predicting Drug Synergy Based on Multitask Learning
Xin Chen1, Lingyun Luo1,2, Cong Shen3
1School of Computer Science, University of South China, Hengyang, 421001, Hunan, China.
Abstract:
To make better use of all kinds of knowledge to predict drug synergy, it is crucial to successfully establish a drug synergy prediction model and leverage the reconstruction of sparse known drug targets. Therefore, we present an in silico method that predicts the synergy scores of drug pairs based on multitask learning (DSML) that could fuse drug targets, protein-protein interactions, anatomical therapeutic chemical codes, a priori knowledge of drug combinations. To simultaneously reconstruct drug-target protein interactions and synergistic drug combinations, DSML benefits indirectly from the associations with relation through proteins. In cross-validation experiments, DSML improved the ability to predict drug synergy. Moreover, the reconstruction of drug-target interactions and the incorporation of multisource knowledge significantly improved drug combination predictions by a large margin. The potential drug combinations predicted by DSML demonstrate its ability to predict drug synergy.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Agonism and Antagonism: Quantification
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
Drug Discovery: Overview
Bioequivalence of Drugs: Drugs with Multiple Indications

